Sponsor pipeline

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) clinical trial pipeline

Get alerts when TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)'s trials change

3 active trials 3 recruiting 6 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days

2026-09-10
Trial sites expanded: 40 → 44 locations
NCT06625775 Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors · Phase 1
2026-09-04
Trial sites expanded: 35 → 38 locations
NCT06343402 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer · Phase 1

Active trials by phase

Phase 1
3

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT06625775 Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors Solid Tumor, Adult Recruiting 2026-10-01
NCT06343402 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer Non-small Cell Lung Cancer Recruiting 2026-09-03
NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer Non-Small Cell Lung Cancer Recruiting 2026-06-02

Disease areas by active trials

Lung Cancer (3) · Colorectal Cancer (2) · Non-Small Cell Lung Cancer (NSCLC) (2) · Breast Cancer (1) · HER2-Positive Cancer (1) · Pancreatic Cancer (1)

Get alerts when TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free